SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001808805-22-000041
Filing Date
2022-04-28
Accepted
2022-04-28 16:03:33
Documents
5
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A nautilusdef14a20220614a.htm DEF 14A 568234
2 GRAPHIC nautilus_primarylogoxbluea.jpg GRAPHIC 291090
3 GRAPHIC proxycard001.jpg GRAPHIC 120998
4 GRAPHIC proxycard002.jpg GRAPHIC 111010
5 GRAPHIC sujalsignaturea.jpg GRAPHIC 6720
  Complete submission text file 0001808805-22-000041.txt   1273050
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39434 | Film No.: 22866406
SIC: 3826 Laboratory Analytical Instruments